Enrico M.
- Country
- Italy
- Department
- Struttura Complessa Nefrologia
Research Overview
- Frexalimab Versus Tacrolimus for Prevention of Kidney Graft Rejection in Adult Kidney Transplant Recipients
- Evaluation of Pegcetacoplan for Reducing Proteinuria in Adults and Adolescents with Focal Segmental Glomerulosclerosis
- Phase 2 Study on the Efficacy and Safety of Riliprubart in Antibody-Mediated Rejection Prevention and Treatment in Adult Kidney Transplant Recipients
Data & Insights
Has run more than one trial at 56 of 277 partner sites.
Specializations
Cardiovascular Care in Renal Disease
The investigator specializes in treating atherosclerotic cardiovascular disease in patients with end-stage kidney disease (ESKD). Their research encompasses innovative approaches to managing cardiovascular complications in dialysis patients.
- Cardiovascular risk management in ESKD
- Inflammatory biomarker assessment
- Dialysis-related cardiovascular complications
The focus includes evaluation of novel therapeutic agents targeting inflammatory markers in dialysis patients.
Transplant Medicine
The investigator conducts research in transplant rejection prevention and treatment, with particular emphasis on antibody-mediated rejection (AMR) management. Their work involves evaluating novel therapeutic approaches for transplant recipients.
- AMR prevention strategies
- Active rejection treatment
- Transplant immunology
The research explores innovative immunological interventions in transplant medicine.
Vascular Access Management
The investigator focuses on arteriovenous graft thrombosis prevention in hemodialysis patients. Their expertise includes developing strategies to maintain vascular access patency in patients receiving regular dialysis treatment.
- Thrombosis prevention
- Vascular access maintenance
- Hemodialysis complications
The research aims to improve outcomes in vascular access management for dialysis patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.